Weekly Executive & Director Moves (July 14)

by | Jul 14, 2023

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Moves in this Issue

CEO

ARMP, CASA, CMC, EYPT, IRNT, LPSN, PEBO, VMI, VSTM

CFO

ACHC, ASO, BANC, BXC, CBOE, ELEV, ENVX, FFIE, HLGN, ICHR, INNV, INTA, KRMD, LESL, LL, LSI, LYFT, OPAD, SMLR, TKAT, TMP, VMI, XWEL

Directors

ABUS, ACET, AMSWA, ARMP, ATR, AVTE, BCOV, BFH, CAPR, CDLX, CRMZ, DAVE, DVA, ELEV, ESRT, GRPN, HYZN, IDXX, INVA, IRNT, ISEE, LNT, LPSN, NBIX, NNBR, NPCE, OCUL, OLPX, OMCL, OMGA, OSBC, PEBO, PHR, PLCE, PLUG, PLUR, RWAY, SHAK, SLDP, SMG, TMO, UDMY, VMI, VVV, WD, YORW, ZUMZ

CEO Moves

COMMERCIAL METALS CO (CMC)
Leaving: CEO – Barbara Smith ( 6.0 yrs; 21.6% TSR)
Replaced by: Peter R Matt

Peter R. Matt, the Company’s President, will assume the role of Chief Executive Officer and President of the Company, effective September 1, 2023. Mr. Matt will continue as a member of the Board, which he joined in June 2020. Mr. Matt, 60, has served as the Company’s President since April 9, 2023. Prior to serving as the Company’s President, Mr. Matt served as Executive Vice President and Chief Fi…read full bio

EYEPOINT PHARMACEUTICALS INC (EYPT)
Leaving: CEO – Nancy Lurker ( 6.8 yrs; -21.0% TSR)
Replaced by: Jay S Duker

Jay Duker, M.D. Dr. Duker has served as our President and Chief Operating Officer since January of 2023 and Chief Operating Officer since November 2021. Dr. Duker served as our Chief Strategic Scientific Officer on a part-time basis in 2020, after having served as an independent member of our Board of Directors since 2016. Dr. Duker was the Director of the New England Eye Center from 2001 to 2021 …read full bio

LIVEPERSON INC (LPSN)
Leaving: CEO – Robert P Locascio ( 28.1 yrs; -2.6% TSR)
Replaced by: TBD

PEOPLES BANCORP INC (PEBO)
Leaving: CEO – Charles W Sulerzyski ( 13.0 yrs; 10.4% TSR)
Replaced by: Tyler J Wilcox

Mr. Wilcox will also be elected as a director of each of Peoples and Peoples Bank effective April 1, 2024, in order to fill the vacancy created on each Board of Directors by Mr. Sulerzyski’s retirement. Mr. Wilcox, who has been an employee of Peoples since 2008, will serve in the position of Senior Executive Vice President, Chief Operating Officer, of each of Peoples and Peoples Bank in a transiti…read full bio

VALMONT INDUSTRIES INC (VMI)
Leaving: CEO – Stephen G Kaniewski ( 5.5 yrs; 11.6% TSR)
Replaced by: Avner M Applbaum

Mr. Applbaum, age 52, has served as Valmont’s Executive Vice President and Chief Financial Officer since March 2020. Previously he served as Chief Financial Officer and Chief Operating Officer of Double E Company, an equipment manufacturer, from 2017 to March 2020….read full bio

VERASTEM INC (VSTM)
Leaving: CEO – Brian M Stuglik ( 4.0 yrs; -15.8% TSR)
Replaced by: Daniel J Patterson

Daniel Paterson, 62, Dan Paterson joined Verastem Oncology in 2011 and has served as Chief Operating Officer since 2014 and President since 2019. He has more than 30 years of experience at healthcare and biotechnology companies. At Verastem Oncology, he spearheaded the acquisition of lead compound avutometinib and strategic direction t…read full bio

CFO Moves

ACADEMY SPORTS & OUTDOORS INC (ASO)
Leaving: CFO – Michael P Mullican ( 2.2 yrs; 27.3% TSR)
Replaced by: Earl Carlton (Carl) Ford, IV

Mr. Ford, 45, served as the Company’s Senior Vice President, Finance, since joining the Company in January 2019. Prior to joining the Company, Mr. Ford spent 15 years, from April 2003 to December 2018, with Belk, Inc., a department store chain, serving as Vice President of Financial Planning & Analysis, Vice President of Internal Audit between May 2009 and April 2011, and, prior to th…read full bio

BANC OF CALIFORNIA INC (BANC)
Leaving: CFO – Raymond J Rindone ( .3 yrs; )
Replaced by: Joseph Kauder

Joseph Kauder, age 55, Mr. Kauder has more than 30 years of experience in the banking and financial services industry, including more than 15 years in executive finance positions at Wells Fargo Corporation. Most recently, Mr. Kauder served as Executive Vice President and Chief Financial Officer for Wells Fargo’s Commercial Banking Segment, with over $200 billion in assets, and nearly…read full bio

CBOE GLOBAL MARKETS INC (CBOE)
Leaving: CFO – Brian N Schell ( 5.5 yrs; 2.5% TSR)
Replaced by: Jill Griebenow

Jill M. Griebenow. Ms. Griebenow is our Senior Vice President, Chief Accounting Officer, a position she has held since August 2018. Previously, she served as Chief Financial Officer, Europe of the Company’s subsidiary Cboe Europe, a position she was appointed to upon the Company’s acquisition of Bats. She also previously served as Chief Financial Officer, Europe of Bats’ subsidiary Bats Europe Lim…read full bio

ELEVATION ONCOLOGY INC (ELEV)
Leaving: CFO – Joseph J Ferra Jr ( 2.1 yrs; -63.5% TSR)
Replaced by: Tammy Furlong

Ms. Furlong, age 52, has served as the Vice President of Finance and Accounting of the Company since April 2021. Prior to joining the Company, Ms. Furlong served as a finance consultant from September 2018 to March 2021, where she focused on capital raising, strategic transactions and finance operations for multiple biotechnology and pharmaceutical companies. Ms. Furlong is a certified public a…read full bio

ENOVIX CORP (ENVX)
Leaving: CFO – Steffen Pietzke ( 2.0 yrs; -5.6% TSR)
Replaced by: Farhan Ahmad

From July of 2018 through June of 2023, Mr. Ahmad held certain roles at Micron Technology, Inc., a publicly-traded global semiconductor company, including Vice President, Investor Relations and Finance Strategy and Senior Director, Head of Investor Relations, and was responsible for driving long range strategic planning and cost competitiveness. From January 2011 through July 2018, Mr.&nbs…read full bio

FARADAY FUTURE INTELLIGENT ELECTRIC INC (FFIE)
Leaving: CFO – Yun Han ( .8 yrs; -72.1% TSR)
Replaced by: Jonathan Maroko

Mr. Maroko, age 38, has most recently served as external Chief Financial Officer for various companies during their growth phase including Gladstein Neandross & Associates, Willow, Lifeforce A-Frame Brands, Kwell Labs and Arcadia Earth. Mr. Maroko brings over 17 years of investment and finance experience to the role of CFO, previously serving as Discretionary Global Macro Portfolio Manager …read full bio

LIFE STORAGE INC (LSI)
Leaving: CFO – Alexander E. Gress ( .5 yrs; 30.2% TSR)
Replaced by: David Dodman

David Dodman, age 49, has served as Chief Operating Officer of the Company since 2022 and previously served as Senior Vice President of Strategic Planning and Investor Relations since joining the Company in 2018. Prior to joining the Company, Mr. Dodman held various corporate strategy, mergers and acquisitions and operational roles at KeyCorp, First Niagara Financial Group, Inc. and Lockheed Marti…read full bio

LYFT INC (LYFT)
Leaving: CFO – Lisa Blackwood-Kapral ( .2 yrs; )
Replaced by: Erin Brewer

Ms. Brewer, 52, served as Managing Director Enterprise Finance at Charles Schwab & Co., Inc., a financial services company, from May 2020 to October 2022. From September 2018 to April 2020, Ms. Brewer served as Head of Strategy and Finance at Atlassian Corporation, a software development company. Previously, Ms. Brewer served in a variety of roles for McKesson Corporation from August 2005 t…read full bio

SEMLER SCIENTIFIC INC (SMLR)
Leaving: CFO – Andrew B Weinstein ( 4.8 yrs; -3.4% TSR)
Replaced by: Renae Cormier

Ms. Cormier, age 51, will continue as Semler’s head of corporate communications and business strategy, a role she has held since May 2022. In this capacity, Ms. Cormier led Semler’s investor relations efforts and was instrumental in helping to shape the overall direction of Semler. From 2001 to until joining Semler, Ms. Cormier held various positions at investment management firms. …read full bio

TAKUNG ART CO LTD (TKAT)
Leaving: CFO – Jiang Qian ( 1.5 yrs; -79.4% TSR)
Replaced by: Yaobin Wang

Mr. Yaobin Wang has served as the Finance Director & Operation Data Director of Lvmama.com since August 2018. From June 2017 to July 2018, Mr. Wang served as the Director and CFO of SunMoon Food Company Limited (SGX: AAJ). Mr. Wang served as an Investment Director of Yiguo Group from June 2017 to July 2018 and prior to that as Finance Director from April 2015 to June 2017. Mr. Wang received…read full bio

TOMPKINS FINANCIAL CORP (TMP)
Leaving: CFO – Francis M Fetsko ( 22.8 yrs; 8.0% TSR)
Replaced by: Matthew Tomazin

Mr. Tomazin, age 38, has served as Senior Vice President and Treasurer of the Company and the Bank since February 2021, having joined the Company in April 2019 as Vice President and Senior Quantitative Analyst. From 2008 until April 2019, Mr. Tomazin served in accounting and strategic finance roles, most recently as Vice President and Assistant Treasurer with NBT Bancorp Inc. (NASDAQ: NBTB),&nb…read full bio

VALMONT INDUSTRIES INC (VMI)
Leaving: CFO – Avner M Applbaum ( 3.3 yrs; 24.7% TSR)
Replaced by: Timothy Francis

Mr. Francis, age 46, has served as Senior Vice President and Finance Business Partner, Global Operations since June 2022. Previously he served as Senior Vice President and Controller from June 2014 to June 2022….read full bio

XWELL INC (XWEL)
Leaving: CFO – Omar A. Haynes ( 1.1 yrs; -66.3% TSR)
Replaced by: Suzanne A. Scrabis

Ms. Scrabis, 53, moved into a Program Manager, Technology Platforms role for Rockwell Automation in 2020 after serving as Chief Financial Officer for MAVERICK Technologies Holdings, LLC, a privately held independent systems integrator based in Columbia, Illinois from 2006 to December, 2019.   As CFO, she helped lead the acquisition of Maverick Technologies by Rockwell Automation …read full bio

 

Director Joins

ADICET BIO INC (ACET)
Katie Peng

Ms. Peng brings extensive industry and commercial expertise to the Board. She currently serves as Chief Commercial Officer at Denali Therapeutics Inc., where she is leading the global commercialization efforts of Denali’s pipeline. Previously Ms. Peng served as the Senior Vice President, He…read full bio


AEROVATE THERAPEUTICS INC (AVTE)
Habib J Dable

Mr. Dable currently serves as a member of the Boards of Directors of Blueprint Medicines Corporation and PepGen Inc., and also served as a member of the Boards of Directors of Albiero Pharm, Inc. and Millendo Therapeutics Inc. As President and Chief Executive Officer of Acceleron Pharma Inc., Mr….read full bio


AMERICAN SOFTWARE INC (AMSWA)
Celena Matlock

Ms. Celena Matlock, age 51, Ms. Matlock joins as the ninth member of American Software’s Board of Directors. Ms. read full bio


ARBUTUS BIOPHARMA CORP (ABUS)
Melissa Rewolinski

Dr. Rewolinski currently serves as principal of MVR Consulting, where she specializes in providing counsel to small and mid-size biotechnology and pharmaceutical companies. Earlier she held a number of senior level R&D positions for Intercept, rising to Senior Vice President, Head of Technica…read full bio


CAPRICOR THERAPEUTICS INC (CAPR)
Paul Gisbert Auwaerter

Dr. Auwaerter is the Sherrilyn and Ken Fisher Professor of Medicine at the Johns Hopkins University School of Medicine, serving as the Clinical Director for the Division of Infectious Diseases and Director of the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases. Dr. Auwaerter…read full bio


Creditriskmonitor Com Inc (CRMZ)
Lisa A Reisman

Lisa Reisman is currently co-founder and CEO of MetalMiner. With a background in physical metal trading, management consulting and executive leadership, Lisa has a proven entrepreneurial track record.  Through her Companies’ Insights platform, they offer a SaaS …read full bio


Creditriskmonitor Com Inc (CRMZ)
Brigitte W Muehlmann

Brigitte Muehlmann is currently a Professor at Babson College and an Adjunct Professor at Texas A&M University School of Law.  She serves as a Director of Babson Global, Inc., and the USA Branch of the International Fiscal Association.  Entrepreneurial leader…read full bio


DAVE INC (DAVE)
Yadin Rozov

Mr. Rozov is also the founder and Managing Partner of Terrace Edge Ventures LLC, and previously a Partner of GoldenTree Asset Management LLC, a leading global credit asset management firm. Additionally, he was a Partner and Managing Director at Moelis & Company, where he headed the …read full bio


ELEVATION ONCOLOGY INC (ELEV)
Joseph J Ferra Jr

Joseph J. Ferra, Jr. has served as our Interim Chief Executive Officer and President since January 2023 and as our Chief Financial Officer since June 2021. Mr. Ferra joined us from Syros Pharmaceuticals, Inc., where he served as Chief Financial Officer from March 2018 to June 2021. Prior to Syros, M…read full bio


EMPIRE STATE REALTY TRUST INC (ESRT)
Hannah Yang

Hannah is a business leader with deep expertise in strategic growth, media and digital transformation. For more than a decade, she played a key role in the development of The New York Times Company’s global subscription business. Hannah is currently the Chief Growth and Customer Officer of …read full bio


OCULAR THERAPEUTIX INC (OCUL)
Adrienne L Graves

Dr. Graves was designated as a Class I member of the Board to serve until the 2024 annual meeting of the stockholders of the Company and thereafter until her successor has been duly elected and qualified, or until her earlier death, resignation or removal. Dr. Graves, age 69, served as President and…read full bio


OMEGA THERAPEUTICS INC (OMGA)
Christian S Schade

Mr. Schade is a seasoned executive with over 30 years of experience across private and public biopharma companies, including proven leadership in several executive roles. He joined Flagship Pioneering as a Growth Partner in January of this year. Previously, he was President and Chief Executive Of…read full bio


OMNICELL INC (OMCL)
Kaushik Ghoshal

Mr. Ghoshal is an established technology leader who brings more than 30 years of experience across multiple industries including finance, semiconductors, and healthcare. In Mr. Ghoshal’s current role as President of SaaS for ResMed, Inc. (“ResMed”), he leads the Company’s …read full bio


PLUG POWER INC (PLUG)
Patrick Joggerst

Patrick Joggerst Patrick Joggerst has been designated as a Class III director to serve until the Company’s 2026 annual meeting of the stockholders or until his successor has been duly elected and qualified, or until his earlier death, removal or resignation. The Board has determined that Mr. Jogger…read full bio


PLUG POWER INC (PLUG)
Mark J Bonney

Mark J. Bonney Mark J. Bonney has been designated as a Class II director to serve until the Company’s 2025 annual meeting of the stockholders or until his successor has been duly elected and qualified, or until his earlier death, removal or resignation, and as the Chair of the Audit Committee. The …read full bio


PLURI INC (PLUR)
Lorne Kenneth Abony

Mr. Abony, age 53, is an experienced entrepreneur who has decades of experience building and scaling multi-billion-dollar global businesses – both public and private companies – across multiple industries. He has served as a member of the board of directors of Yooma Wellness Inc. (CSE…read full bio


SHAKE SHACK INC (SHAK)
Charles J Chapman III

Mr. Chapman was appointed as a Class III member who will stand for election at the 2024 Annual Meeting. T he Board has determined that Mr. Chapman is independent under the listing standards of the New York Stock Exchange and the Company’s Corporate Governance Guidelines. Mr. Chapman has been appoint…read full bio


SOLID POWER INC (SLDP)
Kaled Awada

Mr. Awada has more than 20 years of global leadership and human resources management expertise, including experience working with suppliers to automotive companies. He also brings experience in the matters of corporate strategy, organizational development, and environmental, health and safet…read full bio


SOLID POWER INC (SLDP)
Susan M Kreh

Ms. Kreh has more than 35 years of finance and information technology expertise, including experience in defining and leading strategy development and execution, enterprise risk management, cybersecurity, and global operations. She currently serves as Chief Financial Officer and Chief Inform…read full bio


ZUMIEZ INC (ZUMZ)
Guy Matthew Harkless

Mr. Harkless has served from August 2015 to April 2023 in operating and strategy roles for Foot Locker, Inc. Most recently, from July 2020 to April 2023, Mr. Harkless led the North American operations as Senior Vice President and General Manager of the Champs Sports division, following …read full bio

Director Exits

ALLIANT ENERGY CORP (LNT)
Susan D Whiting ( 10.0 yrs; 11.4% TSR)
Committees: Audit, Compensation and Personnel, Executive, Operations

APTARGROUP INC (ATR)
Maritza Gomez Montiel ( 8.2 yrs; 9.0% TSR)
Committees: Audit

ARMATA PHARMACEUTICALS INC (ARMP)
Brian Varnum ( 1.9 yrs; -42.4% TSR)

BRIGHTCOVE INC (BCOV)
Ritcha Ranjan ( 2.9 yrs; -22.5% TSR)
Committees: Audit, Compensation

CARDLYTICS INC (CDLX)
Chris Suh ( 1.8 yrs; -74.3% TSR)
Committees: Audit

INNOVIVA INC (INVA)
Deborah Birx ( 2.3 yrs; 2.4% TSR)
Committees: Audit, Integration, Nominating (and Governance)

IRONNET INC (IRNT)
Andre Pienaar ( 1.9 yrs; -86.0% TSR)
Committees: Nominating (and Governance)

IVERIC BIO INC (ISEE)
Adrienne L Graves ( 4.6 yrs; 88.3% TSR)
Committees: Compensation, Compensation and Talent Strategy, Research and Development

IVERIC BIO INC (ISEE)
Axel Bolte ( 15.9 yrs; 3.3% TSR)
Committees: Audit, Business Development and Strategy, Nominating (and Governance)

IVERIC BIO INC (ISEE)
Calvin W Roberts ( 4.5 yrs; 105.8% TSR)
Committees: Audit, Compensation, Compensation and Talent Strategy, Nominating (and Governance), Research and Development

IVERIC BIO INC (ISEE)
Christine Ann Miller ( 1.5 yrs; 80.1% TSR)
Committees: Business Development and Strategy, Nominating (and Governance), Research and Development

IVERIC BIO INC (ISEE)
Glenn Sblendorio ( 6.2 yrs; 50.0% TSR)

IVERIC BIO INC (ISEE)
Jane Henderson ( 5.5 yrs; 58.2% TSR)
Committees: Audit, Compensation, Compensation and Talent Strategy, Nominating (and Governance)

IVERIC BIO INC (ISEE)
Mark S Blumenkranz ( 3.0 yrs; 96.8% TSR)
Committees: Business Development and Strategy, Compensation, Compensation and Talent Strategy, Nominating (and Governance), Research and Development

IVERIC BIO INC (ISEE)
Pravin Dugel ( .5 yrs; 78.0% TSR)

LIVEPERSON INC (LPSN)
Robert P Locascio ( 27.7 yrs; -2.6% TSR)
Committees: Executive

NN INC (NNBR)
Robert E Brunner ( 11.4 yrs; -10.6% TSR)
Committees: Compensation, Nominating (and Governance)

NN INC (NNBR)
Shihab A Kuran ( 2.4 yrs; -35.9% TSR)
Committees: Compensation, Nominating (and Governance)

OLD SECOND BANCORP INC (OSBC)
William B Skoglund ( 31.5 yrs; 1.8% TSR)
Committees: Loan, Nominating (and Governance), Risk, Risk and Insurance

PEOPLES BANCORP INC (PEBO)
Charles W Sulerzyski ( 13.0 yrs; 10.4% TSR)
Committees: Executive, Risk

PLUG POWER INC (PLUG)
Jonathan M Silver ( 5.1 yrs; 37.3% TSR)
Committees: Nominating (and Governance), Regulatory Affairs

RUNWAY GROWTH FINANCE CORP (RWAY)
Brian K Laibow ( 6.5 yrs; 4.0% TSR)


SCOTTS MIRACLE-GRO CO (SMG)
Gerald Volas ( 2.0 yrs; -40.3% TSR)
Committees: Audit, Finance

VALMONT INDUSTRIES INC (VMI)
Stephen G Kaniewski ( 5.5 yrs; 11.6% TSR)


WALKER & DUNLOP INC (WD)
Howard W Smith III ( 13.8 yrs; 19.2% TSR)


YORK WATER CO (YORW)
Cynthia Dotzel ( 4.5 yrs; 14.1% TSR)
Committees: Executive

Recent Analysis

Daily SPAC Update – Feb 20, 2024

DWAC Sets Deal Vote. CMCA, CFFS, BNIX Extension Votes Set. Deal Deck for LBBB. GIA + QT Imaging Deal Vote. ACAC Announces Deal with Foxx Development.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.